2026 NPPES data Oncology Pharmacist NPI 1194199521 PHARMD, CPP
Verify on CMS →

Ethan Sebring, PHARMD, CPP

Oncology Pharmacist in Wilmington, North Carolina.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,720 in Oncology Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
448
Medicare Part D claims · 165 beneficiaries · Oncology Pharmacist avg: 160
Generic prescribing
88%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Ethan Sebring, PHARMD, CPP filed 448 Medicare Part D claims in 2023 as a Oncology Pharmacist in Wilmington, North Carolina, prescribing 88% generic.

448
Part D claims, 2023
88%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Ethan Sebring, PHARMD, CPP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

448 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Ethan Sebring, PHARMD, CPP?

Quality data not reported

NPI registry status

Active

Issued 11/23/2015

NPI 1194199521

Primary specialty

Oncology Pharmacist

Niche

1,720 US NPIs in this specialty

Medicare Part D claims

448 180% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in North Carolina

How Oncology Pharmacist compares to other specialties among North Carolina providers

North Carolina providers
Clinical Social Worker - 7.1%Clinical Social Worker7.1%Behavior Technician - 6.4%Behavior Technician6.4%Pharmacist - 5%Pharmacist5%Student in an Organized Health Care Education/Training Program - 4.5%Student in an Organized Health Care Education/Training Program4.5%Physical Therapist - 4.3%Physical Therapist4.3%Physician Assistant - 4.2%Physician Assistant4.2%Oncology Pharmacist - 0%Oncology Pharmacist0%
Largest specialties in North Carolina (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oncology Pharmacist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Ethan Sebring, PHARMD, CPP appears in the CMS NPPES registry as an Oncology Pharmacist provider holding PHARMD, CPP credentials at 2131 S 17TH ST, Wilmington, NC, 28401, with a listed phone of (910) 667-7245. NPI 1194199521 was issued on 11/23/2015.

Medicare Part D records for calendar year 2023 show 448 prescription claims written by this provider, covering 165 Medicare beneficiaries and totaling roughly $749K in drug spend, split 13% brand-name and 88% generic by claim count, with an opioid prescribing rate of 2.9%.

Oncology Pharmacist is a narrow specialty nationwide, with 1,720 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2131 S 17TH ST
Wilmington, NC 28401

Provider Details

NPI 1194199521
Specialty Oncology Pharmacist
Credentials PHARMD, CPP
Gender Male
NPI Issued 11/23/2015

Brand vs generic prescribing mix · Typical

Ethan Sebring, PHARMD, CPP - brand share 13.0%
Oncology Pharmacist average

13% brand-name claims vs 88% generic, on 448 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

448
Total Claims
$749K
Total Drug Cost
165
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
546
Total Day Supply
11,406
Brand vs Generic
13% brand / 88% generic
Brand Drug Cost
$644K
Generic Drug Cost
$105K
Opioid Claims
13 (2.9% rate)

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
2.14
Gender Split
45% female / 55% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Ethan Sebring, PHARMD, CPP prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prochlorperazine Maleate
81
Ondansetron Hcl
67
Dexamethasone
29
Ondansetron Odt
Ondansetron
19
Valacyclovir
Valacyclovir Hcl
19
Abiraterone Acetate
14
Promethazine Hcl
13
Xarelto
Rivaroxaban
13
Prednisone
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Pharmacist Overview

How Ethan Sebring, PHARMD, CPP fits within the Oncology Pharmacist landscape nationally.

1,720
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

Ethan Sebring, PHARMD, CPP's 448 claims are above the specialty average of 160.

Nearby Oncology Pharmacist Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Sebring.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Oncology Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Ethan Sebring, PHARMD, CPP's specialty?
Ethan Sebring, PHARMD, CPP specializes in Oncology Pharmacist and practices in Wilmington, North Carolina. Credentials: PHARMD, CPP.
How much does Ethan Sebring, PHARMD, CPP prescribe under Medicare Part D?
In 2023, Ethan Sebring, PHARMD, CPP wrote 448 Medicare Part D claims totaling $749K in drug costs for 165 beneficiaries.
Where is Ethan Sebring, PHARMD, CPP located?
Ethan Sebring, PHARMD, CPP is located at 2131 S 17TH ST, Wilmington, NC, 28401. Phone: (910) 667-7245.
What is Ethan Sebring, PHARMD, CPP's NPI number?
Ethan Sebring, PHARMD, CPP's National Provider Identifier (NPI) is 1194199521, issued on 11/23/2015.
Does Ethan Sebring, PHARMD, CPP prescribe more brand-name or generic drugs?
Ethan Sebring, PHARMD, CPP's prescribing is 13% brand-name and 88% generic drugs by claim count, with $644K in brand drug costs.
Does Ethan Sebring, PHARMD, CPP prescribe opioids?
Yes, Ethan Sebring, PHARMD, CPP had 13 opioid claims in 2023 with an opioid prescribing rate of 2.9%.
How many Oncology Pharmacist providers are there in the US?
There are 1,720 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
What drugs does Ethan Sebring, PHARMD, CPP prescribe most often?
Based on 2023 Medicare Part D data, Ethan Sebring, PHARMD, CPP's most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Hcl, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ethan Sebring, PHARMD, CPP accept Medicare?
Ethan Sebring, PHARMD, CPP appears in CMS Medicare data with 448 Part D claims and 165 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ethan Sebring, PHARMD, CPP's credentials?
Ethan Sebring, PHARMD, CPP's NPI is 1194199521 with credentials PHARMD, CPP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.